BCAL Diagnostics Limited (AU:BDX) has released an update.
BCAL Diagnostics Limited has announced a General Meeting for shareholders on 15 July 2024 to vote on major resolutions, including the ratification of prior share issues and the approval for new share issuances as detailed in their Explanatory Statement. Shareholders’ participation is crucial as these decisions will impact their holdings and the future direction of the company. The meeting is set to take place in Sydney, and only shareholders registered by 13 July 2024, will be eligible to vote.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
